# MS-RR-P03
Reviewer status: R1 not reviewed, R2 not reviewed (no MS-RR notes file in this round) | Approved before this round: no

## Reviewer notes
| note id | ruling | what changed (field paths) |
| --- | --- | --- |
| (none) | n/a | No reviewer notes for this case. All changes below are own findings and the condition plan (plans/MS-RR.md). |

## Own findings
| dim | severity | field path | finding | action |
| --- | --- | --- | --- | --- |
| C | blocker | `followup_outputs[1]` (`request_repeat_mri_3months`) | A brain MRI from three months in the future carried the only typical lesions (Dawson-finger periventricular lesion with ring enhancement, juxtacortical lesion); the label rested on a scan the agent cannot have at assessment (plan F). | FIXED: follow-up deleted. Its two lesions moved into the initial MS-protocol MRI (`initial_tool_outputs.mri.findings[4]`, `[5]`) as the left occipital-horn periventricular lesion with incomplete ring enhancement and the right superior frontal juxtacortical lesion, and a right dorsal pontine lesion was added (`findings[6]`, fits the end-gaze nystagmus and vertigo); `additional_observations` no longer deny infratentorial/juxtacortical lesions; impression rewritten as findings with a within-imaging read. |
| B | major | `followup_outputs[0]` spine MRI | Spine MRI normal although the left-hand paraesthesias and the resolved episode of unsteadiness in the dark point to the dorsal columns; impression "No evidence of spinal cord demyelination". | FIXED: short left dorsal C5-C6 lesion (7 mm, under one segment, under half the cross-section, non-enhancing) added to findings, measurements and impression; thoracic cord and conus reported normal. DIS is now 4 of 5 regions. |
| A | major | `followup_outputs[2]` (`interpret_labs` `request_somatosensory_evoked_potentials`) | SSEP filed as a lab panel ("All values within normal limits"), wrong tool (plan G1). | FIXED: deleted. |
| D | major | `initial_tool_outputs.drug_interactions.general` | Empty block whose summary repeated the drug criterion's expected evidence (guard failure: scoring-key leak). | FIXED: real class-level check of sertraline, sumatriptan and acetaminophen against anti-CD20, S1P, DMF and teriflunomide, aspirin-allergy line, pre-DMT screening and teriflunomide warnings; guard passes. |
| C | major | `followup_outputs` literature (`search_migraine_white_matter_lesions_vs_MS`) | Unverifiable sources ("Neurology Reviews 2023"), 2017 criteria presented as current, "follow-up imaging at 3-6 months" as the strategy. | FIXED: three verifiable sources (Montalban 2025 McDonald 2024; Solomon 2023 differential consensus; Dobson 2013 OCB meta-analysis), general population-level findings, canonical 2024 summary (plan O). Placed last in the pathway. |
| A | major | `ground_truth.action_criteria` | Template criteria: label = rationale; literature required with a long `query`; drug check with non-schema keys `proposed_class`/`screen_for`; CSF needing OCB+IgG index+kFLC together; labs needing 9 analytes incl. CMP/calcium/glucose that the scorer cannot match; duplicate free-text citations. | FIXED per plan A: brain MRI, spine MRI, labs `{CBC, vitamin_B12, TSH, HIV}` required; CSF recommended with OCB or kFLC alternatives; VEP optional; drug check optional `{}`; literature optional `{}`, no expected evidence, last. Case-specific rationales and expected evidence; bracketed keys only. Order: brain, spine, labs, CSF, VEP, drug, literature. |
| A | minor | `ground_truth.stop_rule` | Literature in `required_before_assessment`; `max_additional_actions` 0. | FIXED: required criteria only (brain MRI, spine MRI, labs); max 3. |
| A | minor | `ground_truth.sequence_constraints[0]` | Reason text and McDonald 2017 citation. | FIXED: canonical soft brain MRI before CSF, no citation. |
| C | major | `ground_truth.assessment.required_recommendations` | Template musts: DIS/DIT recitals, AQP4/MOG test disguised as a must (no such criterion or result in this case), IV methylprednisolone for a relapse the patient does not have (normal exam, episode resolved), generic lifestyle line. | FIXED: formulation must (4 of 5 regions, DIT not required, OCB-negative does not exclude), revise the migraine attribution, DMT by activity, pre-DMT screening, vitamin D replacement (value 21 ng/mL). |
| C | major | `ground_truth.assessment.prohibited_recommendations` | Natalizumab/JCV (no JCV result), fingolimod/cardiac (no cardiac reason), teriflunomide contraception (patient is a man), cord-MRI omission (no myelopathic signs) prohibitions irrelevant to the case. | FIXED: deleted; kept non-specific lesions, chronic steroids, live vaccines; added case-specific prohibitions (migraine/anxiety attribution, rejecting MS on negative OCB, steroids without a functional relapse). |
| C | major | `ground_truth.differential` | NMOSD and MOGAD "high", neurosarcoidosis "moderate" with nothing in the case supporting them; migraine-related lesions (the case's central mimic) absent. | FIXED: assessment-time differential with case data: migraine WML, NMOSD, MOGAD, SLE/CTD (ANA row), B12 myelopathy, functional/anxiety, all low with supports/against. |
| C | major | `ground_truth.key_clinical_evidence` | Engineering lines ("July 2026 review", "Tier per..."), wrong facts ("three regions establish DIS", T1 black holes give DIT), tumefactive open-ring line, DMT-choice line, AQP4 ELISA line. | FIXED: rebuilt per plan D (syndrome, DIS 4 of 5 line, DIT, migraine supporting-evidence line, CSF, ANA, vitamin D). |
| B | major | `initial_tool_outputs.labs.panels.CBC` | Female reference ranges and an Hb of 12.4 g/dL (anaemic for a man) in a male patient (template carry-over). | FIXED: male ranges (RBC 4.5-5.9, Hb 13.5-17.5, Hct 41-53) with values RBC 4.85, Hb 14.6, Hct 43.5, MCV 89.7 (arithmetic consistent); ferritin range 30-400 (male). |
| D | minor | `initial_tool_outputs.labs.panels["Mimic exclusion"]` | HIV row with leaked significance ("excludes this reversible mimic"), empty unit and range. | FIXED: panel renamed `Serology`, row "HIV-1/2 antigen/antibody", reference "Non-reactive", `clinical_significance` null. |
| B | minor | `initial_tool_outputs.csf` | OCB "Not detected in CSF or serum (matched pattern)" self-contradictory; obsolete myelin basic protein; glucose ratio 0.70 against 59.5/88 = 0.68; interpretation a recital. | FIXED: OCB wording, MBP deleted, kFLC index 2.8 (reference < 6.1) added, ratio 0.68, pattern interpretation. |
| B | minor | `followup_outputs` VEP | Impression "All values within normal limits." (stub). | FIXED: stimulus row and a real normal impression with both eyes' latencies and interocular difference. |
| B | minor | `patient.clinical_history.social_history.occupation` | "software engineer" while the HPI and social history describe a graduate student with thesis deadlines. | FIXED: "Graduate student in computer science (thesis year)". |
| C | minor | `patient.clinical_history.medications[2]` | Ibuprofen as needed in a patient with aspirin urticaria (NSAID cross-reactivity). | FIXED: acetaminophen 1000 mg as needed; aspirin allergy kept. |
| B | minor | `patient.clinical_history.family_history[5]` | Sister aged 22, same age as the patient with no twin mentioned. | FIXED: age 19. |
| B | minor | `ground_truth.red_herrings[1]` | "common in healthy young women" in a man. | FIXED: "young adults"; added red herrings for the outside migraine-attributed MRI and the negative OCB. |
| C | minor | `ground_truth.avoided_actions` | Template rationales with McDonald 2017 / Reich citations. | FIXED: case-tied rationales; `[Wattjes_2021]` for CT and PET, none for EEG, echo, monitoring. |
| A | minor | `fallback_tool_outputs.echo.echo_type` | Missing discriminator value. | FIXED: "TTE". |
| E | minor | `metadata.difficulty_rationale`, `teaching_points` | Relied on McDonald 2017 and the follow-up MRI. | FIXED: 2024 wording; revision fields updated. |

## Changes, in one paragraph a physician can read before re-reviewing

The case remains a 22-year-old man with six months of brief positional vertigo, fatigue and left-hand paraesthesias, an earlier two-week episode of unsteadiness in the dark, an outside MRI read as migraine-related and negative CSF oligoclonal bands. The three-month repeat MRI (a future scan) is gone; instead the initial MS-protocol brain MRI now shows two ovoid periventricular lesions perpendicular to the ventricles (the left one with incomplete ring enhancement), a right superior frontal juxtacortical lesion, a right dorsal pontine lesion and three non-specific subcortical foci, and the spine MRI shows a short left dorsal C5-C6 lesion. DIS is 4 of 5 regions, so the 2024 criteria are met without DIT (present anyway); the cord lesion is the extra evidence that migraine cannot explain. CSF: OCB absent, kFLC index 2.8 (below cutoff), MBP removed. The SSEP stub is deleted, the VEP report is complete and normal, the CBC carries male ranges and values. Required: brain MRI, spine MRI, mimic labs; CSF recommended; VEP, drug check and literature optional (literature last, general and correctly cited). Musts: formulation with the regions, revising the migraine label, DMT by activity, pre-DMT screening, vitamin D replacement; prohibitions now fit a man without cardiac risk or JCV data, and forbid steroids without a functional relapse and rejecting MS on negative OCB. Ibuprofen was replaced by acetaminophen (aspirin urticaria), occupation matches the HPI.

## CENTRAL (requests outside this file: vocabulary, synonyms, library, tests, UI)

- Citation keys `[McDonald_2024]`, `[Wattjes_2021]`, `[NICE_NG220]` used per plan section 1.1 and 5.1 (criteria pack update).
- Diagnosis synonyms (G35.B/G35.C, "demyelinating disease") per plan section 5.2; not hand-edited here.

## Open questions for Andrea (judgment calls you could not settle)

None. Decided: no AQP4/MOG criterion and no result (plan 3.2: no optic neuritis or myelitis attack, short dorsal cord lesion); no steroid must, because the exam is normal and the only attack resolved (NICE NG220 treats relapses that affect function).

## Verification

Adversarial verifier, 24 Oct 2026. Checked against the committed diff (b8be2153) and the final file: every own-finding row is applied (future repeat MRI and SSEP stub gone; spine C5-C6 left dorsal lesion consistent with the left-hand paraesthesias across report, criterion, KCE and differential; male CBC ranges and arithmetic; HIV row neutral; no AQP4/MOG criterion or result, as plan 3.2 decides; stop rule, sequence constraint and tiers match plan 3.5; literature sources verified to exist with correct volume and pages; drug output free of the criterion text, guard passes). DIS count (PV, JC, IT, cord = 4 of 5) matches musts, KCE and metadata. MockServer probe: spine, repeat brain MRI and an off-pathway CT CAP order route correctly.

Found and changed:
- `followup_outputs[1].output.findings[0].value` (VEP stimulus): "60-minute checks" is a unit error (check size is in minutes of arc): now "60 arcmin checks".
- `initial_tool_outputs.csf.glucose_ratio`: ratio 0.68 used a serum glucose of 88 mg/dL while the admission BMP reports 80 mg/dL; labelled as the paired serum glucose at the time of the lumbar puncture so the two values no longer read as a contradiction.

Not changed (checked, sound): red_herrings[0] keeps its pre-existing wording (not new text, no clinical error). Note for CENTRAL: an agent that orders AQP4/MOG here receives the stored panel with no AQP4/MOG row (the lab merge does not answer analytes absent from the case); plan A8 deliberately stores none for this case, so this is a harness/library question, not a case edit.

perfect_agent.py -v: pass. case_io.py check: clean for this case. test_case_guards -k MS-RR-P03: pass.

## Condition audit

Condition auditor, 24 Oct 2026 (uniformity scripts over all 30 MS-RR cases; edits through `case_io`; perfect agent, `case_io check` and the case guards clean afterwards).

- `fallback_tool_outputs.drug_interactions.general.proposed` "(agent not specified on this case's pathway)" -> "Not specified": engineering wording, harmonised with the S cases.
- `ground_truth.red_herrings[0].correct_interpretation` em dash and capitalised NOT removed (house style), meaning unchanged.
